PMID- 28372946
OWN - NLM
STAT- MEDLINE
DCOM- 20170710
LR  - 20180702
IS  - 1873-1740 (Electronic)
IS  - 0033-0620 (Linking)
VI  - 59
IP  - 6
DP  - 2017 May-Jun
TI  - The Role of Embolic Protection in Carotid Stenting Progress in Cardiovascular 
      Diseases (PCVD).
PG  - 612-618
LID - S0033-0620(17)30050-6 [pii]
LID - 10.1016/j.pcad.2017.03.003 [doi]
AB  - Embolic protection device (EPD) use has become ubiquitous and is currently 
      mandated by the Centers for Medicare and Medicaid (CMS) for reimbursement in 
      conjunction with carotid artery stenting (CAS). There are two classes of EPD 
      devices: distal filter EPD (f-EPD) and proximal EPD (p-EPD). Measuring the 
      incremental benefit of one strategy over the other remains problematic for 
      several reasons. The first lies in the difficulty of defining an embolic event as 
      transcranial Doppler and diffusion-weighted magnetic resonance imaging 
      abnormalities may not correlate with clinical events. Next, f-EPD is used more 
      frequently than p-EPD making direct comparisons challenging, as analyses to this 
      point have been underpowered. However, there are several promising emerging 
      techniques and technologies that warrant further investigation.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Kobayashi, Taisei
AU  - Kobayashi T
AD  - Cardiovascular Division, University of Pennsylvania; Penn Cardiovascular 
      Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania.
FAU - Giri, Jay
AU  - Giri J
AD  - Cardiovascular Division, University of Pennsylvania; Penn Cardiovascular 
      Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania. 
      Electronic address: Jay.Giri@uphs.upenn.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170331
PL  - United States
TA  - Prog Cardiovasc Dis
JT  - Progress in cardiovascular diseases
JID - 0376442
SB  - IM
MH  - Angioplasty/adverse effects/*instrumentation
MH  - Carotid Artery Diseases/complications/diagnostic imaging/*therapy
MH  - Diffusion Magnetic Resonance Imaging
MH  - *Embolic Protection Devices
MH  - Humans
MH  - Intracranial Embolism/diagnostic imaging/etiology/prevention & control
MH  - Predictive Value of Tests
MH  - Risk Assessment
MH  - Risk Factors
MH  - *Stents
MH  - Treatment Outcome
MH  - Ultrasonography, Doppler, Transcranial
OTO - NOTNLM
OT  - Carotid artery stenting
OT  - Embolic protection devices
OT  - Stroke
EDAT- 2017/04/05 06:00
MHDA- 2017/07/14 06:00
CRDT- 2017/04/05 06:00
PHST- 2017/03/28 00:00 [received]
PHST- 2017/03/28 00:00 [accepted]
PHST- 2017/04/05 06:00 [pubmed]
PHST- 2017/07/14 06:00 [medline]
PHST- 2017/04/05 06:00 [entrez]
AID - S0033-0620(17)30050-6 [pii]
AID - 10.1016/j.pcad.2017.03.003 [doi]
PST - ppublish
SO  - Prog Cardiovasc Dis. 2017 May-Jun;59(6):612-618. doi: 10.1016/j.pcad.2017.03.003. 
      Epub 2017 Mar 31.